Learn languages naturally with fresh, real content!

tap to translate recording

Explore By Region

flag FDA removes black box warnings from menopause HRT, citing updated evidence.

flag The U.S. FDA will remove black box warnings from menopause hormone replacement therapies, stating that earlier risks such as breast cancer, heart disease, and dementia were overstated due to outdated studies. flag The revision, effective in the coming months, applies to both estrogen-only and combination treatments used for hot flashes, night sweats, and bone loss. flag The agency emphasized that HRT is safe and effective for most women under 60 or within 10 years of menopause when used appropriately. flag A warning about endometrial cancer will remain for certain formulations. flag Health officials welcomed the move as a step toward reducing stigma and improving access, while some experts called for continued transparency in reviewing long-term safety data.

405 Articles